Neural Regeneration Research ›› 2019, Vol. 14 ›› Issue (11): 1905-1906.doi: 10.4103/1673-5374.259614

Previous Articles     Next Articles

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease

Marco T. Nuñez 1, Pedro Chana-Cuevas 2   

  1. 1Faculty of Sciences, Universidad de Chile, Santiago, Chile;
    2Movement Disorders Center, Universidad de Santiago de Chile, Santiago, Chile
  • Online:2019-11-15 Published:2019-11-15
  • Contact: Marco T. Nu?ez, PhD, mnunez@uchile.cl.
  • Supported by:

    This work was supported by FONDEF 17I10095 grant from Comisión Nacional de Investigación Científica y Tecnológica (CONICYT, to MTN).

PDF

106

Abstract:

Neurodegenerative diseases with an iron accumulation component: A wide variety of neurological diseases are characterized by the accumulation of iron in different areas of the central nervous system, include Parkinson’s disease, Huntington disease, Alzheimer’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis, pantothenate kinase-associated neurodegeneration and other neuropathologies associated with brain iron accumulation